<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="22333">Alkylating agents</z:chebi> used either with or without radiation therapy have been associated with the development of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) after treatment of both malignant and nonmalignant disorders </plain></SENT>
<SENT sid="1" pm="."><plain>This report describes seven patients with <z:e sem="disease" ids="C0746341" disease_type="Neoplastic Process" abbrv="">recurrent Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) evaluated for bone marrow transplantation (BMT) who developed chromosomal abnormalities, and emphasizes the importance of bone marrow cytogenetic studies before bone marrow harvest </plain></SENT>
<SENT sid="2" pm="."><plain>Three patients with histologically <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow underwent autologous BMT and subsequently developed an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or ANLL </plain></SENT>
<SENT sid="3" pm="."><plain>Four patients had the clonal abnormality detected before bone marrow harvest and did not proceed to BMT </plain></SENT>
</text></document>